ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $606,050 | -18.8% | 17,000 | +6.2% | 0.00% | – |
| Q2 2023 | $746,400 | +127055.0% | 16,000 | +5.3% | 0.00% | -100.0% |
| Q1 2023 | $587 | -99.8% | 15,200 | +289.7% | 0.00% | – |
| Q4 2021 | $329,000 | +53.0% | 3,900 | +56.0% | 0.00% | – |
| Q3 2021 | $215,000 | -68.1% | 2,500 | -64.3% | 0.00% | -100.0% |
| Q2 2021 | $675,000 | +99.7% | 7,004 | +52.8% | 0.00% | 0.0% |
| Q2 2020 | $338,000 | – | 4,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |